Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

From: Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery Anesthes. 2007;107(2): doi: /01.anes ad.

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Circulating levels of sTNFR and discrepancy between cytotoxicity and immunoreactivity of TNF-α in patients with visceral leishmaniasis I.M. Medeiros,

K. -M. Kaukonen, R. Linko, H. Herwald, L. Lindbom, E. Ruokonen, T

L. Boyanova Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

C-reactive protein as a marker of infection in critically ill patients

Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of.

Herpes zoster in non-hospitalized children

An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford,

E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

Dynamics of serum procalcitonin in patients after major neurosurgery

B. Beović, S. Kreft, J. Osredkar, D. Keše, B. Bonač-Tuma

M. Jensenius, P. -E. Fournier, K. B. Helium, L. Wesslén, G. Caruso, T

R. Cantón Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

M. Jensenius, P. -E. Fournier, K. B. Helium, L. Wesslén, G. Caruso, T

Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. H. Wisplinghoff, H. Seifert,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood-a prospective quasi-randomized controlled trial H. Peltola,

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

Community-acquired pneumonia: the evolving challenge

Retrospective study of CMV retinitis in patients with AIDS

Laboratory diagnosis and biosafety issues of biological warfare agents

M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

A. Bryskier Clinical Microbiology and Infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Training in infectious diseases and tropical medicine in Britain

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia Bo Söderquist, Dan Danielsson,

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia U. Hohenthal, S. Hurme, H. Helenius,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Abstracts Clinical Microbiology and Infection

Serum ferritin levels in West Nile encephalitis

New oral cephalosporins in pediatric community-acquired infections

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

G.C. Schito Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer, Z.F. Forycki, P.M. Shah Clinical Microbiology and Infection Volume 8, Issue 2, Pages 93-100 (February 2002) DOI: 10.1046/j.1469-0691.2002.00349.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Box-plot of body temperature (°C) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections. Clinical Microbiology and Infection 2002 8, 93-100DOI: (10.1046/j.1469-0691.2002.00349.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Box-plot of white blood cell count (WBC) (cells/nL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections. Clinical Microbiology and Infection 2002 8, 93-100DOI: (10.1046/j.1469-0691.2002.00349.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Box-plot of body APACHE II scores in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections. Clinical Microbiology and Infection 2002 8, 93-100DOI: (10.1046/j.1469-0691.2002.00349.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Box-plot of C-reactive protein (CRP) serum concentrations (mg/dL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections. Clinical Microbiology and Infection 2002 8, 93-100DOI: (10.1046/j.1469-0691.2002.00349.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 5 Box-plot of procalcitonin (PCT; ng/mL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections. Clinical Microbiology and Infection 2002 8, 93-100DOI: (10.1046/j.1469-0691.2002.00349.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions